Financials
Financial year 2025
EPHAMED from Frasnes-lez-Anvaing, company number BE0674631733, closed financial year 2025 with a result of € 58,570 after tax. For that financial year EPHAMED recorded a gross margin of € 86,691 and equity of € 47,487. Compared with financial year 2024, the result moved from € 79,342 to € 58,570. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on February 20, 2026.
€ 47,487
▲ 22% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 58,570
▼ 26% vs 2024
Profit after tax over the fiscal year.
€ 53,168
▼ 49% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 50,000 paid out
85 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 5,817
▼ 52% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 4,515
▼ 60% vs 2024
Loans from banks and other lenders, long and short.
€ 1,959
▲ 80% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 9,472
▼ 29% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 35,623 | € 68,542 | € 114,322 | € 86,691 | ▼ 24% |
| Profit after taxes | € 18,871 | € 43,675 | € 79,342 | € 58,570 | ▼ 26% |
| Equity | € 40,900 | € 34,575 | € 38,917 | € 47,487 | ▲ 22% |
| Total debts | € 61,271 | € 77,327 | € 100,750 | € 65,946 | ▼ 35% |
| Cash | € 50,676 | € 28,950 | € 103,818 | € 53,168 | ▼ 49% |
| Retained profit | € 14,900 | € 8,575 | € 12,917 | € 21,487 | ▲ 66% |
| Dividend | € 24,000 | € 50,000 | € 75,000 | € 50,000 | ▼ 33% |
| Bank debt | € 24,831 | € 18,059 | € 11,287 | € 4,515 | ▼ 60% |
| Balance sheet total | € 102,171 | € 111,902 | € 139,667 | € 113,433 | ▼ 19% |
Key figures of EPHAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to EPHAMED?
What happened at EPHAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 58,570 (▼ 26% vs 2024). Source: NBB ↗
- Fabrice CLAISSE became a director. NBB
- New establishment in Frasnes-lez-Anvaing. KBO
- Start of the company according to the CBE. KBO
In short
From € 18,871 profit in 2022 to € 58,570 profit in 2025.
Paid € 68,831 in corporate taxes since 2022.
Best year ever: 2024, with € 79,342 profit.
Paid out € 199,000 in dividends to the owners in total.
Management
Behind EPHAMED are Eric VAN NIEUWENHUYZE and Fabrice CLAISSE.
Directors
According to the 2025 annual accounts
Eric VAN NIEUWENHUYZE
Director
Fabrice CLAISSE
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Rue du Marais(D) 5 A
7912 Frasnes-lez-Anvaing
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
OVH Mail
Hosting
OVH, FR
DNS
OVH DNS
Website info
Features
Security
Details
- Company number
- 0674.631.733
- VAT number
- BE 0674.631.733
- Registered office
- Rue du Marais(D) 5 A, 7912 Frasnes-lez-Anvaing
- Names & denominations
- EPHAMED
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 19 April 2017
- Peppol
- Active · Active since 18 Nov 2025
- Contact
- ephacare.be
- Activities · NACE
Activiteiten van webportalen
Webportalen
Overige niet-gespecialiseerde detailhandel
Ontwerpen van computerprogramma’s
Ontwerpen en programmeren van computerprogramma's
Detailhandel via postorderbedrijven of via internet